Strategies for using mathematical modeling approaches to design and interpret multi-organ microphysiological systems (MPS)
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Recent advances in organ-on-a-chip technology have resulted in numerous examples of microscale systems that faithfully mimic the physiology and pathology of human organs and diseases. The next step in this field, which has already been partially demonstrated at a proof-of-concept level, would be integration of organ modules to construct multiorgan microphysiological systems (MPSs). In particular, there is interest in “body-on-a-chip” models, which recapitulate complex and dynamic interactions between different organs. Integration of multiple organ modules, while faithfully reflecting human physiology in a quantitative sense, will require careful consideration of factors such as relative organ sizes, blood flow rates, cell numbers, and ratios of cell types. The use of a mathematical modeling platform will be an essential element in designing multiorgan MPSs and interpretation of experimental results. Also, extrapolation to in vivo will require robust mathematical modeling techniques. So far, several scaling methods and pharmacokinetic and physiologically based pharmacokinetic models have been applied to multiorgan MPSs, with each method being suitable to a subset of different objectives. Here, we summarize current mathematical methodologies used for the design and interpretation of multiorgan MPSs and suggest important considerations and approaches to allow multiorgan MPSs to recapitulate human physiology and disease progression better, as well as help in vitro to in vivo translation of studies on response to drugs or chemicals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the medium circulation rate is disproportionately slow compared to physiological blood flow, which in turn slows down the transport of nutrients and metabolic processes in tissue models138”
From Human disease models in drug development (2023) · cites this paper as [138]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A General Model for the Origin of Allometric Scaling Laws in Biology
West, G. B., Brown, J. H., & Enquist, B. J. (1997) · Science · doi:10.1126/science.276.5309.122 · Cited by 5,016
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Maschmeyer, I., Lorenz, A. K., Schimek, K., Hasenberg, T., Ramme, A. P., Hübner, J., Lindner, M., Drewell, C., Bauer, S., Thomas, A., et al. (2015) · Lab on a Chip · doi:10.1039/c5lc00392j · Cited by 861
Zhang, Y. S., Aleman, J., Shin, S. R., Kilic, T., Kim, D., Mousavi Shaegh, S. A., Massa, S., Riahi, R., Chae, S., Hu, N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612906114 · Cited by 833
Allometric scaling of metabolic rate from molecules and mitochondria to cells and mammals
West, G. B., Woodruff, W. H., & Brown, J. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012579799 · Cited by 678
Wang, Y. I., Abaci, H. E., & Shuler, M. L. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26045 · Cited by 563
Self-citationA microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
Sung, J. H., Kam, C., & Shuler, M. L. (2010) · Lab on a Chip · doi:10.1039/b917763a · Cited by 484
Self-citationWagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50234a · Cited by 476
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Self-citationReconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis
Frey, O., Misun, P. M., Fluri, D. A., Hengstler, J. G., & Hierlemann, A. (2014) · Nature Communications · doi:10.1038/ncomms5250 · Cited by 387
Cited by
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Self-citationHuman disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Building Digital Twins for Cardiovascular Health: From Principles to Clinical Impact
Sel, K., Osman, D., Zare, F., Shahrbabak, S. M., Brattain, L. J., Hahn, J., Inan, O. T., Mukkamala, R., Palmer, J., Paydarfar, D., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031981 · Cited by 210
“68 For example, there is clearly a vital relationship between the cardiovascular and pulmonary systems that involve blood oxygenation and gaseous exchange.”
BackgroundZheng, F., Xiao, Y., Liu, H., Fan, Y., & Dao, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000024 · Cited by 107
From animal testing to in vitro systems: advancing standardization in microphysiological systems
Reyes, D. R., Esch, M. B., Ewart, L. C., Nasiri, R., Herland, A., Sung, K. E., Piergiovanni, M., Lucchesi, C., Shoemaker, J. T., Vukasinovic, J., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc00994g · Cited by 74
Marrella, A., Fedi, A., Varani, G., Vaccari, I., Fato, M., Firpo, G., Guida, P., Aceto, N., & Scaglione, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245536 · Cited by 70
Computational Simulations in Advanced Microfluidic Devices: A Review
Carvalho, V. M., Rodrigues, R. O., Lima, R. A., & Teixeira, S. (2021) · Micromachines · doi:10.3390/mi12101149 · Cited by 66
“Although a substantial number of review papers exist in the field of microfluidic OoC‐based systems, only a small number have addressed the different approaches using numerical simulations as an auxiliary tool in the development of these devices [11,35,37,43].”
MethodQiao, L., Khalilimeybodi, A., Linden-Santangeli, N. J., & Rangamani, P. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-102723-065309 · Cited by 61
“Furthermore, modeling cross-talk between organ systems is challenging due to the need to integrate data and interactions across multiple spatial scales, from molecular and cellular levels to organ and systemic levels, and across multiple temporal scales, from milliseconds to days and weeks (6, 7).”
BackgroundLiver-on-chips for drug discovery and development
Mehta, V., Karnam, G., & Madgula, V. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 35
Fanizza, F., Campanile, M., Forloni, G., Giordano, C., & Albani, D. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221095339 · Cited by 58
Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs
Sung, J. H. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1908996 · Cited by 58
Self-citationLiu, J., Lu, R., Zheng, X., Hou, W., Wu, X., Zhao, H., Wang, G., & Tian, T. (2023) · Biomaterials Science · doi:10.1039/d2bm01490d · Cited by 54
Lakhera, P., Chaudhary, V., Bhardwaj, B., Kumar, P., & Kumar, S. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100218 · Cited by 52
Advancing Intelligent Organ‐on‐a‐Chip Systems with Comprehensive In Situ Bioanalysis
Li, X., Zhu, H. J., Gu, B., Yao, C., Gu, Y., Xu, W., Zhang, J., He, J., Liu, X., & Li, D. (2024) · Advanced Materials · doi:10.1002/adma.202305268 · Cited by 50
Microfluidic technologies for drug discovery and development: friend or foe?
Elvira, K. S. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.04.009 · Cited by 50
Kim, M., van Noort, D., Sung, J. H., & Park, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413513 · Cited by 48
Self-citationNeziri, S., Köseoğlu, A. E., Köseoğlu, G. D., Özgültekin, B., & Özgentürk, N. Ö. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12487 · Cited by 47
Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS)
Malik, M., Yang, Y., Fathi, P., Mahler, G. J., & Esch, M. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721338 · Cited by 43
“For example, because of the liver’s high metabolic demand and its integral role in drug metabolism, the formulation of a common MPS cell culture medium is often based on liver cell culture medium (Sung et al., 2019).”
BackgroundMethodAdvances in human organs-on-chips and applications for drug screening and personalized medicine
Zhou, C., Li, Z., Lu, K., Liu, Y., Xuan, L., Mao, H., & Wang, X. (2024) · Fundamental Research · doi:10.1016/j.fmre.2023.12.019 · Cited by 44
“…strategy, considering the effects of relative organ sizes, blood flow rates, cell numbers and ratios of cell types, is critical for replication of human physiology, PK/PD study, and translation from the experiment results on multi-organ-on-chip into the predictions of responses in human body [174] .”
Pharmacokinetics‐On‐a‐Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME
Ramadan, Q., Fardous, R. S., Hazaymeh, R., Alshmmari, S. K., & Zourob, M. M. (2021) · Advanced Biology · doi:10.1002/adbi.202100775 · Cited by 42
Heart/liver-on-a-chip as a model for the evaluation of cardiotoxicity induced by chemotherapies
Soltantabar, P., Calubaquib, E. L., Mostafavi, E., Ghazavi, A., & Stefan, M. C. (2021) · Organs-on-a-Chip · doi:10.1016/j.ooc.2021.100008 · Cited by 38
Engineering mechanobiology through organoids‐on‐chip: A strategy to boost therapeutics
Charelli, L. E., Ferreira, J. P. D., Naveira‐Cotta, C. P., & Balbino, T. A. (2021) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3234 · Cited by 34
“Mathematical modeling has become, in recent years, an important tool to predict biological responses of complex and heterogenous in vitro models (Sung et al., 2019).”
BackgroundPriya, S., Mohan, S., Radhika, K., Suyambulingam, I., Baby, B., Redrouthu, R., & Han, S. S. (2025) · ACS Omega · doi:10.1021/acsomega.5c03258 · Cited by 27
Doi, K., Kimura, H., Matsunaga, Y. T., Fujii, T., & Nangaku, M. (2022) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s344725 · Cited by 27
“This collaboration would ensure the definition of the confidence intervals for the data of GoC, the establishment of the predictive models for drug discovery research, and thus, the reduction of the development costs in drug discovery research.(102,103) We believe that the current intensive collaboration between sever…”
BackgroundMicrophysiological systems for the modeling of wound healing and evaluation of pro-healing therapies
Deal, H. E., Brown, A. C., & Daniele, M. A.-A. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00544d · Cited by 26
Microtechnology-based in vitro models: Mimicking liver function and pathophysiology
Lee, S. Y., Kim, D., Sung, J. H., & Sung, J. H. (2021) · APL Bioengineering · doi:10.1063/5.0061896 · Cited by 24
Self-citationTransporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?
Alluri, R. V., Li, R., & Varma, M. V. S. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1749595 · Cited by 23
In silico modeling of endocrine organ-on-a-chip systems
Sung, B. (2022) · Mathematical Biosciences · doi:10.1016/j.mbs.2022.108900 · Cited by 21
Nair, A. L., Mesch, L., Schulz, I., Becker, H., Raible, J., Kiessling, H., Werner, S., Rothbauer, U., Schmees, C., Busche, M., et al. (2021) · Biosensors · doi:10.3390/bios11090314 · Cited by 20
“The inhibition of cell growth in HT29 tumor spheroids under perfusion at the beginning of the culture may be due to the unintended dilution of factors secreted by the cells in case of an excess liquid to cell ratio and highlights the issue of finding and establishing the proper liquid to cell ratio (LoC) in microfluid…”
BackgroundAkalın, A. A., Dedekargınoğlu, B., Choi, S. R., Han, B., & Özçelikkale, A. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03298-8 · Cited by 19
“While straightforward, this method is not successful at reenacting organ-organ interactions since scaling of individual organs should be different (167).”
BackgroundMethodKim, K., Jeong, S., & Sung, G. Y. (2022) · BioChip Journal · doi:10.1007/s13206-022-00092-x · Cited by 19
“Among them, the skin-on-a-chip technique is considered to be the most useful technique for constructing a skin equivalent using a relatively simple and inexpensive method and reproducing the skin [22].”
MethodKaiser, K., Bendixen, S. M., Sørensen, J. A., & Brewer, J. R. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101010 · Cited by 14
“The main advantage of the SOC technique is the relatively simple and inexpensive method and the ability to successfully reproduce the skin, compared to alternatives such as 3D printing and organoids [11,12].”
MethodBioengineered human gut-on-a-chip for advancing non-clinical pharmaco-toxicology
Shin, Y. C., Than, N., Park, S. J., & Kim, H. J. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2365254 · Cited by 14
Integrating Biophysics in Toxicology
Favero, G. D., & Kraegeloh, A. (2020) · Cells · doi:10.3390/cells9051282 · Cited by 14
A similarity scaling approach for organ-on-chip devices
Feng, J. J., & Hedtrich, S. (2022) · Lab on a Chip · doi:10.1039/d2lc00641c · Cited by 13
Microfluidic gut-axis-on-a-chip models for pharmacokinetic-based disease models
Kim, R., & Sung, J. H. (2024) · Biomicrofluidics · doi:10.1063/5.0206271 · Cited by 13
Self-citationCasas, B., Vilén, L., Bauer, S., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Marx, U., Andersson, T. B., Gennemark, P., & Cedersund, G. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010587 · Cited by 13
Cadavid, J. L., Li, N. T., & McGuigan, A. P. (2024) · Biophysics Reviews · doi:10.1063/5.0179125 · Cited by 12
Mun, S., Ahn, J., Jin, G., Kim, H. N., & Bang, S. (2025) · BioChip Journal · doi:10.1007/s13206-025-00230-1 · Cited by 11
“Individual organ modules can be independently and selectively controlled (e.g., disease modeling, aging modeling, or drug treatment) and later assembled [169, 170].”
Development of a Perfusing Small Intestine–Liver Microphysiological System Device
Sakai, Y., Matsumura, M., Yamada, H., Doi, A., Saito, I., Iwao, T., & Matsunaga, T. (2023) · Applied Sciences · doi:10.3390/app131810510 · Cited by 11
“The MPS model functions as a technological system that mimics physiological blood flow, which enhances expression and functions in cells that cannot be suitably tested using technologies such as conventional static culture [3].”
BackgroundMulti-cellular engineered living systems to assess reproductive toxicology
Lopez, I., & Truskey, G. A. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108609 · Cited by 10
Pumped and pumpless microphysiological systems to study (nano)therapeutics
Lee, E. J., Krassin, Z. L., Abaci, H. E., Mahler, G. J., & Esch, M. B. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1911 · Cited by 10
Recent advances and future prospects of functional organ-on-a-chip systems
Moghaddam, A. S., Moghaddam, Z. S., Davachi, S. M., Sarikhani, E., Mahand, S. N., Khonakdar, H. A., Bagher, Z., & Ashammakhi, N. A. (2022) · Materials Chemistry Frontiers · doi:10.1039/d2qm00072e · Cited by 9
Thinking in 3 dimensions: philosophies of the microenvironment in organoids and organs-on-chip
Caianiello, S., Bertolaso, M., & Militello, G. (2023) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-023-00560-z · Cited by 9
Construction of 3D hierarchical tissue platforms for modeling diabetes
Kim, M., & Jang, J. (2021) · APL Bioengineering · doi:10.1063/5.0055128 · Cited by 8
Advancements in Kidney-on-Chip: Antibiotic-Induced Kidney Injury and Future Directions
Kim, M., Lee, Y., Seo, G. M., & Park, S. (2024) · BioChip Journal · doi:10.1007/s13206-024-00160-4 · Cited by 7
“However, a notable limitation is the lack of consideration for liver and kidney culture areas or the volume ratio between media and tissue, critical factors for accurately reflecting human physiology [85].”
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Marin, T. M., Indolfo, N. D. C., Rocco, S. A., Carvalho, M. D. O., Dias, M. M., Bento, G. I. V., Bortot, L. O., Schuck, D. C., Lorencini, M., & Pagani, E. (2020) · Journal of Visualized Experiments · doi:10.3791/60184 · Cited by 7
Pin, C., Collins, T. A., Gibbs, M. A., & Kimko, H. H. C. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00580-2 · Cited by 6
Hickman, J. J., Huh, D., & Kamm, R. D. (2019) · APL Bioengineering · doi:10.1063/1.5130170 · Cited by 6
From organ-on-a-chip towards body-on-a-chip
Sung, J. H. (2022) · Biocell · doi:10.32604/biocell.2022.019055 · Cited by 5
Self-citationFabrication and Use of a Pumpless Microfluidic Lymphatic Vessel Chip
Fathi, P., & Esch, M. B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1693-2_11 · Cited by 5
Hsu, E. W., Wang, K., Tsang, Y. P., Himmelfarb, J., Yeung, C. K., & Kelly, E. J. (2026) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2026.2633283 · Cited by 4
Microphysiological Systems: Transforming Biomedical and Clinical Research
Sahoo, O. S., Tyagi, A., Sharma, A. K., Gill, G. S., Dhar, R., & Karmakar, S. (2026) · Biotechnology and Bioengineering · doi:10.1002/bit.70229 · Cited by 4
Miller, P. G., Huang, E. H., Fisher, R. C., & Shuler, M. L. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28890 · Cited by 4
“…MPS to assess toxicity, immune response, absorption, metabolism, excretion, metastasis, and mathematical modeling have been developed to assist in designing and interpreting results (e.g., Sung, Wang, and Shuler 2019; McAleer et al. 2019; Punt, 2020; Sasserath et al. 2020; Jouybar et al. 2023).”
Self-citationInnovative Platforms in Regenerative Medicine: Bridging Research and Clinical Solutions
Jalali, S. N., Fathi, Z., & Mohebbi, S. (2025) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb-158285 · Cited by 4
Multiorgan-on-a-chip: Design and Applications
Khan, H., Khan, S. A., & Parvez, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00009-7 · Cited by 3
Jeong, M., Park, K., Jung, D., Shin, S., Lee, J., Ko, J., Bang, S., & Ahn, J. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103050 · Cited by 2
“In such systems, individual single-organ modules are interconnected through shared micro-fluidic circuits that permit the exchange of metabolites, soluble ligands such as growth factors, cytokines, and hormones, as well as extracellular vesicles and exosomes [228].”
MATHEMATICAL DECODING OF THE CORRELATION BETWEEN DIFFERENT ORGANS’ ACTIVITIES: A REVIEW
Abdullah, J., Kašík, V., Penhaker, M., Krejcar, O., Panwar, A., & NAMAZI, H. (2025) · Fractals · doi:10.1142/s0218348x25300120 · Cited by 1
Kang, S. J., Bong, S. H., Jo, M. J., Lee, J. M., Yoon, M. S., Park, S., Lee, Y., Shin, Y., Lee, H. J., Park, C., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091117 · Cited by 1
“In this configuration, PK behavior emerges not solely from externally programmed concentration waveforms but from intercompartmental fluid exchange that mimics physiological circulation [54,56].”
InfluentialReferences Part I and Recommended Textbooks and References for Further Reading
Heinzle, E., Dunn, I. J., Ingham, J., & Přenosil, J. E. (2021) · Wiley eBooks · doi:10.1002/9783527685332.ref
Merging On-chip and In-silico Modelling for Improved Understanding of Complex Biological Systems
Bertani, F. R., Bretti, G., Businaro, L., Ninno, A. D., Gerardino, A., & Natalini, R. (2023) · SEMA SIMAI Springer series · doi:10.1007/978-3-031-35715-2_2
Dharod, A. (2025) · Preprints.org · doi:10.20944/preprints202512.0525.v1
Monchablon, M. (2023) · theses.fr (ABES) · doi:10.70675/1674d15ez05eaz4b9ezb932z6d4cd7d64426
Lee, S. Y., Yoo, S. J., & Sung, J. H. (2026) · BioChip Journal · doi:10.1007/s13206-026-00267-w
Self-citationAdipose tissue-on-Chip platforms for disease modelling, drug discovery and pharmacokinetic modelling
Castañé, H., Spangenberger, C., de Souza, I. R., Kristoforus, T., Lazarevski, L., Yim, J., Cipriano, M., Hjuler, S. T., Özkan, A., Petrie, T. A., et al. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115971
Katsouleas, K., Hammel, J. H., & Gerecht, S. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1927687
“…shear gradients, and network-level resistance, metrics that are difficult to obtain experimentally in models with disrupted flow profiles (Mirzapour-Shafiyi et al., 2025; Sung et al., 2019; Zhao et al., 2021; Ham et al., 2023; Gruionu et al., 2024; Rajeeva Pandian et al., 2026; Rota et al., 2023).”
Metadata
- Authors
- Sung, J. H., Wang, Y., & Shuler, M. L.
- Affiliations
- Cornell University (US)
- Corresponding author
- Shuler, Michael L.
- Venue
- APL Bioengineering
- Publisher
- AIP Publishing
- Published
- 2019-06-01
- Volume
- 3
- Issue
- 2
- Pages
- 021501-021501
- ISSN
- 2473-2877 (ISSN-L)
- PMC
- PMC6586554
- OpenAlex
- W2951213634
- Cited by
- 66
- References
- 53
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 13 · 2023: 7 · 2022: 12 · 2021: 17 · 2020: 4 · 2019: 1
- FWCI
- 0.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor, 19 d)
- creativecommons.org/licenses/by/4.0/ (tdm, 19 d)
- Locations
- APL Bioengineering (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health (R44TR01326, U01CA214300)
- National Research Foundation of Korea (2016R1D1A1B03934710)
- Korea Evaluation Institute of Industrial Technology (R0004073)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, body-on-a-chip, mathematical modeling, scaling methods, physiologically based pharmacokinetic modeling, in vitro-in vivo extrapolation, drug response, disease modeling, blood flow rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.